Long-CoV-III-21 trial shows positive results for bovhyaluronidase azoximer in post-COVID pulmonary sequelae
Petrovax introduced at the moment the optimistic outcomes from "Lengthy-CoV-III-21," a randomized, double-blind, placebo-controlled trial evaluating the efficacy and security ...
